Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |